Prostaglandin E2 alteration in contraceptive consumers: as a risk factor for inflammatory diseases

Pour, Maryam Sanjary; Fallah, Soudabeh; Chadegani, Azra Rabbani

doi:10.1007/s00404-012-2661-3

Arch Gynecol Obstet

2012

DOI: 10.1007/s00404-012-2661-3

|View full text |Cite

Prostaglandin E2 alteration in contraceptive consumers: as a risk factor for inflammatory diseases

Maryam Sanjary Pour

Soudabeh Fallah

Azra Rabbani Chadegani

Abstract: It is suggested that the increase of Prostaglandin E2 and atherogenic lipid levels may be related to their probable effects in response to various pathological and physiological properties of COCs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Prostaglandin E2 alteration in contraceptive consumers: as a risk factor for inflammatory diseases

Abstract: It is suggested that the increase of Prostaglandin E2 and atherogenic lipid levels may be related to their probable effects in response to various pathological and physiological properties of COCs.

Cited by 1 publication

References 30 publications

Polyphenol supplementation inhibits physiological increase of prostaglandin E2 during reproductive period – A randomized clinical trial

Polyphenol supplementation inhibits physiological increase of prostaglandin E2 during reproductive period – A randomized clinical trial

Contact Info

Product

Resources

About